HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel mechanisms and signaling pathways of esophageal ulcer healing: the role of prostaglandin EP2 receptors, cAMP, and pCREB.

Abstract
Clinical studies indicate that prostaglandins of E class (PGEs) may promote healing of tissue injury e.g., gastroduodenal and dermal ulcers. However, the precise roles of PGEs, their E-prostanoid (EP) receptors, signaling pathways including cAMP and cAMP response element-binding protein (CREB), and their relation to VEGF and angiogenesis in the tissue injury healing process remain unknown, forming the rationale for this study. Using an esophageal ulcer model in rats, we demonstrated that esophageal mucosa expresses predominantly EP2 receptors and that esophageal ulceration triggers an increase in expression of the EP2 receptor, activation of CREB (the downstream target of the cAMP signaling), and enhanced VEGF gene expression. Treatment of rats with misoprostol, a PGE1 analog capable of activating EP receptors, enhanced phosphorylation of CREB, stimulated VEGF expression and angiogenesis, and accelerated esophageal ulcer healing. In cultured human esophageal epithelial (HET-1A) cells, misoprostol increased intracellular cAMP levels (by 163-fold), induced phosphorylation of CREB, and stimulated VEGF expression. A cAMP analog (Sp-cAMP) mimicked, whereas an inhibitor of cAMP-dependent protein kinase A (Rp-cAMP) blocked, these effects of misoprostol. These results indicate that the EP2/cAMP/protein kinase A pathway mediates the stimulatory effect of PGEs on angiogenesis essential for tissue injury healing via the induction of CREB activity and VEGF expression.
AuthorsAmrita Ahluwalia, Dolgor Baatar, Michael K Jones, Andrzej S Tarnawski
JournalAmerican journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol) Vol. 307 Issue 6 Pg. G602-10 (Sep 15 2014) ISSN: 1522-1547 [Electronic] United States
PMID25059824 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • CREB1 protein, human
  • Cyclic AMP Response Element-Binding Protein
  • PTGER2 protein, human
  • Protein Kinase Inhibitors
  • Ptger2 protein, rat
  • RNA, Messenger
  • Receptors, Prostaglandin E, EP2 Subtype
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, rat
  • Misoprostol
  • Cyclic AMP
  • CREB-Binding Protein
  • Crebbp protein, rat
  • Cyclic AMP-Dependent Protein Kinases
Topics
  • Animals
  • CREB-Binding Protein (metabolism)
  • Cell Line
  • Cyclic AMP (metabolism)
  • Cyclic AMP Response Element-Binding Protein (metabolism)
  • Cyclic AMP-Dependent Protein Kinases (antagonists & inhibitors, metabolism)
  • Disease Models, Animal
  • Esophageal Diseases (genetics, metabolism, pathology, physiopathology)
  • Esophagus (blood supply, drug effects, metabolism, pathology)
  • Humans
  • Male
  • Misoprostol (pharmacology)
  • Mucous Membrane (metabolism, pathology)
  • Neovascularization, Physiologic
  • Phosphorylation
  • Protein Kinase Inhibitors (pharmacology)
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Prostaglandin E, EP2 Subtype (drug effects, metabolism)
  • Second Messenger Systems
  • Time Factors
  • Ulcer (genetics, metabolism, pathology, physiopathology)
  • Up-Regulation
  • Vascular Endothelial Growth Factor A (genetics, metabolism)
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: